Larimar Therapeutics, Inc. (LRMR) vs Sagimet Biosciences Inc. (SGMT)
A side-by-side comparison of Larimar Therapeutics, Inc. and Sagimet Biosciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LRMR
Larimar Therapeutics, Inc.
$2.80HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
SGMT
Sagimet Biosciences Inc.
$8.78HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — LRMR vs SGMT
growth of $100 · dividends reinvested · last 3yLRMR -9.5% (-3.3%/yr)SGMT -43.4% (-17.3%/yr)LRMR compounded faster over this window
LRMR SGMT
LRMR vs SGMT: by the numbers
- •LRMR is the larger company ($290M vs $286M market cap).
Metrics side by side
Valuation
| Metric | LRMR | SGMT |
|---|---|---|
| P/B ratio | 2.28 | 1.12 |
Profitability
| Metric | LRMR | SGMT |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -135.50% | -18.38% |
| ROIC | -136.49% | -20.40% |
Growth (annualized)
| Metric | LRMR | SGMT |
|---|---|---|
| Total return CAGR (5Y) | -23.91% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.